SCHEMBL30952958

SCHEMBL30952958

Cn1nccc1C(=O)N[C@H](C(=O)Nc1cc(CC(=O)NCCC(F)(F)F)ccn1)C(C1CC1)C1CC1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ IL17A Q16552 2/20 0.37
▸ GSK3B P49841 6/20 0.36
▸ CDK2 P24941 5/20 0.36
▸ CCNE1 P24864 4/20 0.36
▸ DYRK1A Q13627 2/20 0.36
▸ TAS1R3 Q7RTX0 1/20 0.35
▸ TAS1R1 Q7RTX1 1/20 0.35
▸ TAS1R2 Q8TE23 1/20 0.35
▸ KMT2A Q03164 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ MAPK1 P28482 1/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ NR3C2 P08235 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ MBOAT4 Q96T53 1/20 0.32
▸ MAPK13 O15264 1/20 0.32
▸ MAPK14 Q16539 1/20 0.32
▸ WNT1 P04628 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30952984 0.88 IL17A (0.37) IL17AGSK3BCDK2DYRK1ATAS1R3
SCHEMBL30953481 0.83 GSK3B (0.37) IL17AGSK3BCDK2CCNE1DYRK1A
SCHEMBL30953392 0.82 CCNE1 (0.41) GSK3BCDK2CCNE1KMT2ANR3C2
SCHEMBL30952940 0.79 IL17A (0.39) IL17AGSK3BCDK2CCNE1TAS1R3
SCHEMBL30953046 0.77 IL17A (0.38) IL17AGSK3BCDK2CCNE1TAS1R3
SCHEMBL30953025 0.74 IL17A (0.47) IL17AGSK3BDYRK1ANR3C2MAPK14
SCHEMBL30953100 0.71 GSK3B (0.36) GSK3BCDK2CCNE1DYRK1AKMT2A
SCHEMBL30953405 0.70 CYP3A4 (0.40) GSK3BCDK2CCNE1KMT2ANR3C2
SCHEMBL30953409 0.70 CYP3A4 (0.40) GSK3BCDK2CCNE1KMT2ANR3C2
SCHEMBL24876265 0.70 MEN1 (0.36) IL17AKMT2AL3MBTL1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP claimed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO claimed
EP-4630115-A1 THERAPEUTIC COMPOUNDS Sanofi (FR) 2025-10-15 — — EP disclosed
WO-2024121427-A1 THERAPEUTIC COMPOUNDS SANOFI (FR) 2024-06-13 — — WO disclosed
Send feedback